Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma
Wolford, Juliet E., Bai, Jiaru, Moore, Kathleen N., Kristeleit, Rebecca, Monk, Bradley J., Tewari, Krishnansu S.Volume:
157
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2020.02.030
Date:
May, 2020
File:
PDF, 373 KB
2020